Benevity Launches “Missions,” a Purpose-Driven Employee Engagement Solution
June 28, 2018 07:00 ET
|
Benevity
CALGARY, Alberta, June 28, 2018 (GLOBE NEWSWIRE) -- Benevity, Inc., the global leader in corporate social responsibility and employee engagement software, today announced the launch of its latest...
Benevity Launches “Missions,” a Purpose-Driven Employee Engagement Solution
June 28, 2018 02:00 ET
|
Benevity
GLOUCESTER, The United Kingdom, June 28, 2018 (GLOBE NEWSWIRE) -- Benevity UK (part of Calgary-based Benevity, Inc., the global leader in corporate social responsibility and employee engagement...
Sustainable Brands Reveals Final Program Details for SB’18 Vancouver
May 31, 2018 09:00 ET
|
Sustainable Brands
San Francisco, May 31, 2018 (GLOBE NEWSWIRE) -- SAN FRANCISCO, May 31, 2018 – Sustainable Brands® recently announced final program details for SB’18 Vancouver, running June 4-7 at Vancouver...
Benevity Study Links Employee-Centric Corporate Goodness Programs to Big Gains in Retention
May 31, 2018 07:00 ET
|
Benevity
CALGARY, Alberta, May 31, 2018 (GLOBE NEWSWIRE) -- Benevity, Inc., the global leader in corporate social responsibility and employee engagement software, today announced the results of the Benevity...
Benevity Shares Why More Companies are Joining the #GivingTuesday Movement
November 21, 2017 07:45 ET
|
Benevity
CALGARY, Alberta, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Benevity, Inc., the global leader in workplace giving, volunteering and community investment software, has noted a trend of increased...
THE GREATER GOOD SCIENCE CENTER AT UC BERKELEY AND PROSOCIAL CREATE ONLINE GUIDE AND ESSAY CONTEST FOR TEENS, OFFERING A TOTAL OF $50K
September 26, 2017 08:00 ET
|
ProSocial
LOS ANGELES, CA--(Marketwired - September 26, 2017) - What's your purpose in life? It's one of the biggest questions there is, and it can be especially daunting for teenagers gearing up for college...
Intra-Cellular Therapies Announces Positive Topline Data From 6-Week Open-label Safety Switching Study with Lumateperone in Patients with Schizophrenia
September 07, 2017 07:00 ET
|
Intra-Cellular Therapies, Inc.
Intra-Cellular Therapies to Host a Conference Call Today at 8:30 a.m. ET NEW YORK, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company...
HAVAS GROUP ACQUIRES LEMZ TO BUILD THE MOST MEANINGFUL AGENCY IN THE NETHERLANDS
November 03, 2016 13:32 ET
|
Havas
HAVAS GROUP ACQUIRES LEMZ TO BUILD THE MOST MEANINGFUL AGENCY IN THE NETHERLANDS The Havas Group announced today that it is taking a 100% stake in Amsterdam-based Lemz, a leading full service...
Intra-Cellular Therapies Presents Additional ITI-007 Data at the 5th Biennial Schizophrenia International Research Society (SIRS) Conference
April 06, 2016 07:00 ET
|
Intra-Cellular Therapies Inc.
NEW YORK, April 06, 2016 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS)...
Intra-Cellular Therapies Presents Additional Efficacy and Safety Data From the Positive Phase 3 Clinical Trial of ITI-007 for the Treatment of Schizophrenia and From the Positron Emission Tomography Study
December 09, 2015 16:01 ET
|
Intra-Cellular Therapies Inc.
NEW YORK, Dec. 9, 2015 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS)...